Classification of Chemotherapy-Related Subjective Cognitive Complaints in Breast Cancer Using Brain Functional Connectivity and Activity: A Machine Learning Analysis.

Abstract

The aim of this study was combining multi-level resting-state functional magnetic resonance imaging (rs-fMRI) features with machine learning method to distinguish breast cancer patients with chemotherapy-related subjective cognitive complaints (SCC) from non-chemotherapy (BC) and healthy controls (HC). Forty subjects in SCC group, forty-nine in BC group and thirty-four in HC group were recruited and underwent rs-fMRI scanning. Based on the anatomical automatic labeling brain atlas, the functional metrics of all subjects included functional connectivity, amplitude of low frequency fluctuation and fractional amplitude of low frequency fluctuation, regional homogeneity, voxel-mirrored homotopic connectivity and degree centrality were calculated and extracted as features set. Then, the rs-fMRI features were selected by two-sample t-test, removing variables with a high pairwise correlation and least absolute shrinkage and selection operator regression. Finally, the support vector machine models were built for classification (SCC vs. BC, SCC vs. HC). Thirty-eight features (SCC vs. BC) and seventeen features (SCC vs. HC) were selected separately, and the accuracy of the models were 82.0% and 91.9%, respectively. These findings demonstrated a valid machine learning approach that effectively distinguished breast cancer patients with chemotherapy-related SCC from non-chemotherapy and healthy controls, providing potential neuroimaging evidence for early diagnosis and clinical intervention of chemotherapy-related SCC.